Literature DB >> 17157206

Toll like receptors and acute allograft rejection.

Daniel R Goldstein1.   

Abstract

Toll like receptors (TLR) are critical innate immune receptors expressed on a variety of cells including dendritic cells that are activated by the presence of invading pathogens. However, there is emerging evidence that TLR signaling participates in inflammation that may occur in the absence of overt infection. In solid organ transplantation there is increasing evidence, both in experimental and human studies, that TLR activation is involved in the innate immune recognition of allografts. Further investigation of how innate immunity impacts solid organ transplantation may lead to improved therapies for transplant recipients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157206     DOI: 10.1016/j.trim.2006.09.012

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  8 in total

Review 1.  Immunology in the Clinic Review Series; focus on host responses: invariant natural killer T cell activation following transplantation.

Authors:  J-P Jukes; N D Jones
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

2.  Host MyD88 signaling protects against acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  S Xing; X Zhang; J H Liu; X Huang; P Zhou
Journal:  Clin Exp Immunol       Date:  2018-10-14       Impact factor: 4.330

3.  A critical role for the TLR4/TRIF pathway in allogeneic hematopoietic cell rejection by innate immune cells.

Authors:  Hong Xu; Jun Yan; Ziqiang Zhu; Lala-Rukh Hussain; Yiming Huang; Chuanlin Ding; Larry D Bozulic; Yujie Wen; Suzanne T Ildstad
Journal:  Cell Transplant       Date:  2012-11-08       Impact factor: 4.064

4.  TLR agonists prevent the establishment of allogeneic hematopoietic chimerism in mice treated with costimulation blockade.

Authors:  David M Miller; Thomas B Thornley; Todd Pearson; Annie J Kruger; Masahiro Yamazaki; Leonard D Shultz; Raymond M Welsh; Michael A Brehm; Aldo A Rossini; Dale L Greiner
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

5.  TLR signals promote IL-6/IL-17-dependent transplant rejection.

Authors:  Luqiu Chen; Emily Ahmed; Tongmin Wang; Ying Wang; Jordi Ochando; Anita S Chong; Maria-Luisa Alegre
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

6.  Knockdown of toll-like receptor 4 signaling pathways ameliorate bone graft rejection in a mouse model of allograft transplantation.

Authors:  Jeng-Long Hsieh; Po-Chuan Shen; Po-Ting Wu; I-Ming Jou; Chao-Liang Wu; Ai-Li Shiau; Chrong-Reen Wang; Hao-Earn Chong; Shu-Han Chuang; Jia-Shiou Peng; Shih-Yao Chen
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

7.  mRNA Expression of Interferon Regulatory Factors during Acute Rejection of Liver Transplants in Patients with Autoimmune Hepatitis.

Authors:  M Nasiri; B Geramizadeh; S H Nabavizadeh; S A Male-Hosseini; M H Karimi; I Saadat
Journal:  Int J Organ Transplant Med       Date:  2018-02-01

8.  Association between IRF1 Gene Expression and Liver Enzymes in HBV-infected Liver Transplant Recipients with and without Experience of Rejection.

Authors:  S H Nabavizadeh; S Janfeshan; M H Karimi; A Eidi; R Yaghobi; A Afshari; B Geramizadeh; S A Malek-Hosseini; F Kafilzadeh
Journal:  Int J Organ Transplant Med       Date:  2018-05-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.